Medical supervision ensures your protocol supports hormone balance, recovery, and long-term health instead of creating hidden risks
Benefits of Semaglutide for Type 2 Diabetes Patients For patients with type 2 diabetes, semaglutide offers dual benefits: improved glycemic control and weight loss
PwCs Appetite for Disruption: What GLP-1 Means for Consumer Markets report, based on a survey of more than 2,300 UK adults, shares insights on who is using GLP1s and how their behaviour is changing across six categories: food, alcohol, supplements, apparel, restaurants and fitness
Standard semaglutide titration: Weeks 1-4: 0.25 mg weekly Weeks 5-8: 0.5 mg weekly Weeks 9-12: 1.0 mg weekly Week 13+: 1.7 mg or 2.4 mg weekly (target dose) Hashimoto's-adjusted approach: Weeks 1-6: 0.25 mg weekly (extended to allow thyroid monitoring at week 6) Weeks 7-12: 0.5 mg weekly (TSH check before increasing) Weeks 13-16: 1.0 mg weekly Week 17+: Assess whether higher doses are needed The extended timeline allows for thyroid function checks at each step, ensuring levothyroxine doses are adjusted proactively rather than reactively
The rising incidence of the disease is expected to further drive demand for glucagon like peptide drugs